Infections of the musculoskeletal system present a serious problem with regard to the field of orthopaedic and trauma medicine. The aim of the experiment described in this study is to develop a resorbable nanostructured composite layer with the controlled elution of antibiotics. The layer is Vancomycin and its degradation products was observed following 14 days of incubation.
Introduction
The infection of implanted endoprostheses represents a serious problem as far as orthopaedic and trauma surgery is concerned. Indeed, it is often associated with devastating consequences and treatment presents a substantial challenge for surgeons. Despite the fact that a range of more or less successful methods are available, none of them is considered a method of first choice. One of the ways in which to increase the efficacy of the therapy is to employ a local antibiotic delivery system. The local antibiotic treatment of prosthetic joint infection as opposed to the use of systemic antibiotics enjoys the advantage of achieving high antibiotic concentrations which exceed the minimum inhibitory Polymethylmethacrylate (PMMA) bone cement is commonly used for the fixation of joint prostheses.
In the late 1960s antibiotic impregnated cement was considered to provide prevention from infection [2] . However, it has since been established that PMMA provides an initial burst release of antibiotics with the larger part of the loaded antibiotic remaining within the cement thus preventing PMMA from providing an effective long-term anti-inflammatory function [3, 4] . A further problem consists of the exothermic reaction of the bone cement during its polymerization which, to a significant extent, limits the types of antibiotics that can be effectively incorporated into the cement [5] . Moreover, it may accelerate the conversion of Vancomycin into crystalline degradation products and thus lead to a significant decrease in antimicrobial activity. In addition, a number of investigators have demonstrated that biofilm can be easily formed on the surface of antibiotic-loaded cement [6] [7] [8] . Thus, with a view to overcoming these disadvantages, the study focuses on the development of a re-sorbable nanostructured composite layer based on natural and synthetic polymers [4, 9] modified by means of calcium phosphate nanoparticles [10] .
The aim of the study was to develop a biodegradable nanostructured composite layer with the controlled elution of Vancomycin. It is expected that such a layer will be used particularly in the case of known prosthetic joint infections or as a preventative procedure regarding primary joint replacement in a potentially infected site. The layer will provide a bone/implant (titanium alloy)
bioactive interface which will enhance the physiological healing process, will be capable of filling bone defects and will act as a powerful antibacterial agent against those microorganisms susceptible to
Vancomycin. The layer is composed of collagen (type I, isolated from calf skin), hydroxyapatite nanoparticles and Vancomycin hydrochloride. The material composition of the various layers imitates the composition of real bone tissue. Three different layer compositions were analysed the aim of which was to verify the potential effect of hydroxyapatite on the release of Vancomycin. However, it is important to mention at this point that the application of collagen in the field of tissue engineering is limited due to its poor mechanical properties, high rate of swelling in water, low structural stability and low resistivity against the enzymatic degradation of its untreated form [11] . A number of crosslinking agents can be used in order to both improve its mechanical properties and slow down the biodegradation rate of collagen-based materials. Chemical cross-linking is achieved principally through covalent amine/imine linkage. The cross-linking agents and conditions employed in this study include N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC)/N-hydroxysuccinimide (NHS) [12] , genipin (GEN) [13] and nordihydroguaiaretic acid (NDGA) [14, 15] , all of which are commonly used cross-linking agents. The structural properties, swelling ratio and degradation rate of these scaffolds were investigated in detail and subsequently compared in order to determine the optimal cross-linking conditions. The study aimed principally to verify whether the local concentration of the Vancomycin released exceeded the MIC for Vancomycin-resistant Staphylococcus aureus (VRSA >16mg/l) and to monitor the concentrations of active forms of Vancomycin and its degradation products released from the nanostructured composite layer used as local antibiotic carriers in the treatment of osteomyelitis. 
Materials and methods

Fabrication of collagen layers and cross-linking agent selection
A collagen (type I, calf skin, VUP Medical, Czech Republic) solution (5wt%) as received. The second group (EDC/NHS/PBS) was cross-linked using PBS containing EDC/NHS (weight ratio 4:1, EDC: 4.08mg/ml and NHS: 1.02mg/ml). The third group was cross-linked using PBS containing genipin (Sigma Aldrich, Germany) at a concentration of 1.34mg/ml. The last group was cross-linked by means of PBS containing nordihydroguaiaretic acid (Cayman Chemical, USA) at a concentration of 5mg/ml (5mg NDGA, 0.9ml PBS, 0.1ml 0.1N NaOH). Following a reaction period of 24 hours at room temperature (using an orbital shaker, 180rpm), all the layers were washed in 0.1M Na2HPO4 (2 x 45 min), followed by rinsing using deionised water (30 min), placed in the laminar box and dried at room temperature until a constant weight was achieved (up to 48 hours). 
Modification of the collagen layers by means of hydroxyapatite and Vancomycin
Mechanical testing
In order to determine the optimal cross-linking method, mechanical properties were evaluated by means of the conducting of uniaxial tensile tests of rectangular strips of the layers (the average width of the samples was approximately 10 -50mm). During the test procedure the value of strain at failure (the maximum strain sustained by the material before breaking where strain is defined as the ratio of the elongation of the sample to reference length), the ultimate tensile strength (the maximum nominal stress sustained by the material; nominal stress is defined as the ratio of applied force to the reference cross-section of a sample) and the modulus of elasticity (the slope of the tangent made to a stressstrain relationship on the initial linear part) were determined. Tensile tests were conducted using a Zwick/Roell multipurpose testing machine equipped with a built-in video extensometer. By using contrasting marks on the surface of samples, the video extensometer automatically determined the reference length and elongation of the samples. Tensile experiments were conducted at a constant clamp velocity of 0.1mm/s. The loading force was measured by a U9B (±250N, HBM, Germany) force transducer.
Structural stability
The initial analysis of collagen layer stability was conducted by means of degradation testing. The samples were immersed in blood plasma (8 donors of different blood group, sex and age) and incubated at 37°C and a 5% CO2 atmosphere (DH CO2 incubator, Thermo Scientific) with antibiotics where Wo is the initial dried weight of the sample and Wsw is the weight of the swollen sample (n=3).
The weight of the swollen samples was measured following the removal of each sample from the medium and following a 1 minute delay and the removal of any excessive medium surrounding the sample; the dried weight of the samples was measured following lyophilisation.
Degradation tests under physiological conditions were used as the second way in which to assess the stability of the collagenous layers, and UV-VIS spectrophotometry was employed for the quantification of the free amino groups released during the degradation of the samples immersed in the PBS (37°C, Technologies, USA) were employed in order to characterize the in vitro release rates of the Vancomycin and its crystalline degradation antibiotically inactive products over a 21-day period. The HPLC method is described in an article written by Melichercik et al. [22] . 
Statistical evaluation
Results and discussion
Mechanical testing
Each tested group of differently cross-linked samples (EDC/NHS/ETOH, EDC/NHS/PBS, GEN, NDGA) and
original non cross-linked samples (NON) consisted of 8 samples. The stress-strain relationships obtained through uniaxial tensile testing are depicted in Fig. 2 . No statistical differences (p=0.05) were determined between groups for strain at a failure (Fig. 3) . With the exception of the EDC/NHS/PBS variant, all the cross-linked samples exhibited a statistically significant increase in ultimate tensile strength (Fig. 3) . A similar result was observed in the case of the modulus of elasticity. Here again the determined modulus of elasticity values do not prove any significant effect of EDC/NHS/PBS crosslinking on macroscopic mechanical properties. In contrast to the increase in tensile strength and modulus of those samples cross-linked using EDC/NHS/ETOH, genipin and NDGA, there was no observation of the expected effect of cross-linking using EDC/NHS/PBS. The observed decrease in tensile strength and modulus in comparison with that of the other cross-linked samples could be explained by the formation of local stress concentrations due to the early failure of brittle parts of the collagen layers formed following extensive cross-linking subsequent to the application of a higher concentration of EDC/NHS in the aqueous environment [23, 24] . The effect of different cross-linking agents was further analysed by means of the methods described below. 
Structural stability
Accelerated mass loss (Fig. 4) The non-cross-linked layers and those layers cross-linked with EDC/NHS/ETOH exhibited the highest swelling ratios, i.e. 540% and 750% respectively, as soon as after 6 hours (Fig. 5) . These samples demonstrated a decreasing swelling ratio tendency over time. This might have been caused by extensive material degradation (less material available for swelling). In contrast, the EDC/NHS/PBS, GEN and NDGA samples exhibited the lowest statistically significant differences (p=0.05). Indeed, these three groups demonstrated very similar behaviour -all the samples absorbed approximately triple their weight within the first 6 hours of the experiment and, subsequently, the swelling ratio stabilised.
This behaviour would seem to demonstrate the enhancement of structural stability following the application of the cross-linking procedure. The degradation rate, swelling ratio and the determination of released amino acids provide important indices in terms of the evaluation of the structural stability of the collagen layers. For all three analyses, the EDC/NHS/PBS solution was chosen as the optimal cross-linking agent for the further preparation of collagen layers modified by means of Vancomycin and hydroxyapatite nanoparticles. The group of three cross-linking agents (EDC/NHS/PBS, NDGA and GEN) evinced very similar properties when subjected to the evaluation of mechanical properties, degradation rate, swelling ratio and concentration of released free amino acids. However, the results of the in vitro testing of NDGA crosslinked materials, published in literature [25, 26] are ambiguous and often antagonistic. Importantly, in addition to the successful cross-linking effect of genipin coupled with its low toxicity, the related economic issues must be carefully considered.
Vancomycin release
Following the assessment of optimal cross-linking conditions, the preparation procedure was applied The addition of 5 and 15wt% of HA nanoparticles was found to partially influence the release of Vancomycin (Fig. 8 ). There is a deceleration in the rate of release during the first 48 hours. After two days no statistically significant differences were discovered between samples with and without HA.
Thus, the determined levels of Vancomycin release suggest that the modification of collagen by means of HA nanoparticles does not have a strong effect on the evolution of Vancomycin. The incorporation of Vancomycin with calcium phosphate could be limited due to molecule size and, consequently, by chemical steric hindrance as mentioned by Stigter et al. [17] . In addition to the minor effect of HA nanoparticles on Vancomycin release, the modification of collagen by means of calcium phosphate particles may have a positive effect on bioactivity. In other words, the addition of HA increases the rate of osseointegration and does not negatively alter the sustainable release of Vancomycin. 
Conclusions
Based on the analysis of degradation rate, swelling ratio and concentration of released free amino acids, the EDC/NHS/PBS solution was chosen as the optimal cross-linking agent. In addition to the successful cross-linking effect of genipin and its low toxicity, economic considerations were also carefully considered.
Despite the considerable tendency of Vancomycin towards crystalline thermal degradation, levels of the released active form of Vancomycin remained above the MIC for VRSA for more than 3 weeks without the burst releasing effect. The maximum concentration of the released active form of Vancomycin (approx. 265mg/l) exceeded the MIC by up to 17 times. At the end of the experiment (21 days) the MIC was exceeded by up to 6 times (approx. 100mg/l). The balance of Vancomycin and its degradation products was observed after 14 days of incubation and the conversion of Vancomycin to its degradation products was observed at a much slower rate than was reported in previous literature.
The amount of released Vancomycin and its degradation products was approximately 45wt% for all the sample modifications. The total amount of released Vancomycin after 21 days was composed of 25% of Vancomycin in the active form and 75% of inactive degradation products. It can therefore be concluded that the modification of collagen by means of HA nanoparticles can increase the rate of osseointegration and does not negatively influence the sustainable release of Vancomycin.
These results suggest that the local application of high-dose Vancomycin via the use of drug delivery carriers presents a safe therapeutic osteomyelitis treatment method that prevents the development of bacterial resistance. It is planned that the effect of the antibiotic concentration obtained on systemic toxicity and antimicrobial activity working against both gram-positive and gram-negative bacteria will be further evaluated and verified in future research.
